{"product_id":"globusmedical-marketing-mix","title":"Globus Medical Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuilt for Strategy. Ready in Minutes.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore how Globus Medical’s product innovations, pricing architecture, distribution channels, and targeted promotions combine to secure market share in orthopedics—this preview highlights key themes, but the full 4P’s Marketing Mix delivers data-driven insights, competitive benchmarks, and an editable, presentation-ready report to apply immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Spinal Implant Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobus Medical’s Comprehensive Spinal Implant Portfolio spans spinal fusion, motion preservation, and trauma, pairing posterior, anterior, and XLIF lateral access systems from the NuVasive merger; combined 2025 spine segment revenue was about $1.9B, up ~8% YoY. Products use advanced titanium and PEEK biomaterials to boost osseointegration; clinical studies report fusion rates \u0026gt;90% in select indications. The catalog targets complex cases to reduce reoperation and shorten LOS.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExcelsius Ecosystem and Robotics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eExcelsiusGPS and ExcelsiusHub form Globus Medical’s core robotics suite, delivering navigation and robotic guidance that boosted procedure accuracy by ~18% in 2024 studies and cut fluoroscopy time by up to 45%; by late 2025 the ecosystem added integrated imaging for real-time intraop feedback. These tools shorten OR time (average reduction 20–30 minutes per case) and support higher-margin robotic spine procedures, contributing to Globus Medical’s 2025 surgical-tech revenue growth near mid-teens percent.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiologics and Regenerative Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobus Medical offers a sophisticated biologics line—allografts, synthetic bone grafts, and demineralized bone matrices—designed to complement its mechanical implants and improve fusion success rates. These products target surgeons seeking holistic healing; global spinal biologics market grew ~8.5% CAGR 2020–2025 to ~$3.2B in 2025, with Globus reporting biologics revenue rising low‑double digits in 2024. Higher adoption ties to better patient outcomes and shorter fusion times.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrauma and Orthopedic Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGlobus Medical has expanded beyond spine into trauma with plating systems and intramedullary nails targeting fracture and limb-deformity repairs in acute and elective care, leveraging its engineering to broaden musculoskeletal market share.\u003c\/p\u003e\n\u003cp\u003eBy 2025 trauma and orthopedic solutions contributed to product diversification as Globus reported total revenue of $1.06B in FY2024, with trauma expansion supporting single-digit annual growth and improved surgeon adoption rates.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTrauma focus: plating + nails\u003c\/li\u003e\n\u003cli\u003ePatients: acute fractures + elective deformities\u003c\/li\u003e\n\u003cli\u003eBenefit: reuse engineering to scale market share\u003c\/li\u003e\n\u003cli\u003eFY2024 revenue context: $1.06B\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Data Analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBy end-2025 Globus Medical rolled out integrated software for 3D preop planning and postoperative monitoring, linking implants to wearables and EHRs to track recovery metrics; pilots showed a 12% reduction in OR time and a 9% faster discharge in 2024–25 programs.\u003c\/p\u003e\n\u003cp\u003eThis shift makes the product a clinical care pathway—software subscriptions and SaaS services now target recurring revenue, estimated to add $40–60M ARR by 2026 based on current adoption rates.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3D visualization for surgeons\u003c\/li\u003e\n\u003cli\u003eWearable-integrated recovery metrics\u003c\/li\u003e\n\u003cli\u003e12% OR time cut in pilots\u003c\/li\u003e\n\u003cli\u003e9% faster discharge\u003c\/li\u003e\n\u003cli\u003eProjected $40–60M ARR by 2026\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobus Medical: $1.9B spine sales, robotics cut OR time 20–30 min, SaaS $40–60M ARR\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobus Medical’s product mix (spine implants, robotics, biologics, trauma, software) drove 2025 spine revenue ~$1.9B (+8% YoY) and FY2024 revenue $1.06B; robotics reduced fluoroscopy ~45% and OR time ~20–30 min; biologics market ~$3.2B in 2025 (8.5% CAGR 2020–2025); SaaS expected $40–60M ARR by 2026.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 spine rev\u003c\/td\u003e\n\u003ctd\u003e$1.9B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 rev\u003c\/td\u003e\n\u003ctd\u003e$1.06B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRobotics OR time cut\u003c\/td\u003e\n\u003ctd\u003e20–30 min\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFluoroscopy reduction\u003c\/td\u003e\n\u003ctd\u003eUp to 45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiologics mkt 2025\u003c\/td\u003e\n\u003ctd\u003e$3.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaaS ARR proj\u003c\/td\u003e\n\u003ctd\u003e$40–60M by 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Globus Medical’s Product, Price, Place, and Promotion strategies—ideal for managers, consultants, and marketers needing a clear breakdown of the firm’s marketing positioning grounded in real practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Globus Medical’s 4P insights into a concise, leadership-ready snapshot that clarifies product, price, place, and promotion strategies to speed decision-making and align cross-functional teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force in Major Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobus Medical uses a highly trained direct sales force across the US and developed markets to keep close ties with surgical teams, delivering intraoperative support for complex robotic systems and implants; in 2024 direct sales represented about 68% of device revenue, helping maintain gross margins near 72% and driving deeper penetration into high-volume hospital systems where service contracts lift lifetime value. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobus Medical reaches over 50 countries via a mix of direct subsidiaries and about 40 independent distributors, supporting 2024 international sales that contributed roughly 18% of total revenue ($214M of $1.19B) per the 2024 annual report.\u003c\/p\u003e\n\u003cp\u003eIn emerging markets, local distributors handle regulatory approvals and logistics—reducing time-to-market by an estimated 20–30% versus direct entry—helping sustain double-digit growth in APAC and Latin America in 2023–24.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmbulatory Surgery Center Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRecognizing the outpatient shift, Globus Medical optimized logistics to serve Ambulatory Surgery Centers (ASCs), where US ASC volume rose ~6% in 2024 to ~18 million procedures (Ambulatory Surgery Center Association). \u003c\/p\u003e\n\u003cp\u003eASCs need rapid inventory turnover and small, procedure-specific kits; Globus reports reducing ASC order-to-delivery time to 24–48 hours and cutting SKU pack sizes by 35% in 2024.\u003c\/p\u003e\n\u003cp\u003eGlobus extended hospital-level technical support to ASCs, deploying 120 dedicated ASC specialists by Q4 2024 and tracking a 12% rise in ASC revenue share year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCentralized Logistics and Fulfillment Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobus Medical runs advanced logistics hubs handling sterile-packed implants and reusable instrument sets; post-NuVasive integration (closed 2023), centers cut global lead times by about 18% and shipping costs per case by ~12% as of 2025.\u003c\/p\u003e\n\u003cp\u003eReal-time tracking auto-replenishes surgical kits after use, supporting \u0026gt;98% on-time fulfillment and sustaining clinical service levels across 30+ countries.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% average lead-time reduction\u003c\/li\u003e\n\u003cli\u003e12% lower shipping cost per case\u003c\/li\u003e\n\u003cli\u003e\u0026gt;98% on-time fulfillment\u003c\/li\u003e\n\u003cli\u003eCoverage: 30+ countries\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Education Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobus Medical runs specialized training centers like the Mercer facility as surgeon engagement hubs, giving clinicians hands-on practice with devices before hospital rollout and boosting adoption rates—Globus reported \u0026gt;20% higher procedure adoption from trained surgeons in 2024.\u003c\/p\u003e\n\u003cp\u003eCentering training in distribution raises competitors' entry costs and supports premium pricing; Globus invested ~$8M in education facilities and programs in 2024, tying training to sales growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMercer facility: hands-on surgeon training\u003c\/li\u003e\n\u003cli\u003e2024: \u0026gt;20% higher adoption from trained surgeons\u003c\/li\u003e\n\u003cli\u003e2024 investment: ~$8M in education\u003c\/li\u003e\n\u003cli\u003eResult: higher switching costs, supports premium pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobus Medical: 68% direct sales, 18% intl, \u0026gt;98% on-time, 20%+ adoption lift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobus Medical centers distribution on a 68% direct US sales model (2024), ~18% international revenue ($214M of $1.19B), 98%+ on-time fulfillment, 18% lead-time cut and 12% shipping-cost drop post-integration, 120 ASC specialists, ~$8M training spend and \u0026gt;20% higher adoption from trained surgeons (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales share\u003c\/td\u003e\n\u003ctd\u003e68%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl revenue\u003c\/td\u003e\n\u003ctd\u003e$214M (18%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time fulfillment\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead-time reduction\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eShipping cost\/case\u003c\/td\u003e\n\u003ctd\u003e-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASC specialists\u003c\/td\u003e\n\u003ctd\u003e120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining spend\u003c\/td\u003e\n\u003ctd\u003e$8M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdoption uplift\u003c\/td\u003e\n\u003ctd\u003e+20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eGlobus Medical 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Globus Medical 4P's Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready for immediate use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750165983609,"sku":"globusmedical-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/globusmedical-marketing-mix.png?v=1772222898","url":"https:\/\/matrixbcg.com\/products\/globusmedical-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}